Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900021270Phase 4Not yet recruiting
Phase 4 trial of dezocine and sufentanil in postoperative pain (5 arms), sponsored by Tianjin Central Hospital of Obstetrics and Gynecology. Primary endpoints: VAS score and Interaction between dezocine and sufentanil. Planned start Jan 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900021270.